Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.9846
+0.0716 (7.84%)
Aug 4, 2026, 3:21 PM EDT - Market open
Outlook Therapeutics Stock Forecast
OTLK's stock price has decreased by -50.26% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 analysts polled by S&P Global, Outlook Therapeutics stock has a consensus rating of "Buy" and an average price target of $5.40. The average 1-year stock price forecast is 448.45% higher than the current stock price, while the lowest is $1.60 (+62.50%) and the highest is $10 (+915.64%).
Price Target: $5.40 (+448.45%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Outlook Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 1 | 1 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $1.6 | Hold | Reiterates | $1.6 | +62.50% | Jul 27, 2026 |
| BTIG | BTIG | Buy Upgrades $1.61 → $4 | Buy | Upgrades | $1.61 → $4 | +306.26% | Jul 27, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $6 → $10 | Buy | Maintains | $6 → $10 | +915.64% | Jun 10, 2026 |
Financial Forecast
Revenue This Year
4.12M
from 1.41M
Increased by 191.61%
Revenue Next Year
58.00M
from 4.12M
Increased by 1,307.00%
EPS This Year
-0.49
from -1.89
EPS Next Year
-0.16
from -0.49
EPS and Forward PE are based on non-GAAP adjusted numbers.